Bruno Gagnon
Senior Vice President of Clinical Development OperationsMr. Bruno Gagnon, BPharm, MSc., is Senior Vice President of Clinical Development Operations at Spruce Biosciences, Inc. since February 02, 2026. He served as Senior Vice President of Global Clinical Operations at Opthea Limited since September 2022 until September 09, 2024. He is former Senior Vice President of Development Operations at Eidos Therapeutics, a BridgeBio company in San Francisco, CA. He also served as Vice President of Clinical Operations at BioMarin Pharmaceutical. Previously, he held positions of increasing responsibilities at Roche Diagnostics, Chiron and Hoechst Marion Roussel (now Sanofi). he led development operations for BridgeBio Pharma’s affiliate, Eidos Therapeutics, where he oversaw strategic planning and operational execution of clinical trials for the company’s TTR amyloidosis program and played a key role in advancing ATTRUBY® (Acoramidis) towards regulatory approval. Over his career, functions under his leadership have included Global Clinical Trial Management, Patient Advocacy, Medical Writing, Outsourcing and Contracts, Supply Chain Management, Clinical Data Management, Clinical Systems, Document Management and Clinical Training. He holds a bachelor’s degree from the School of Pharmacy, Laval University and a Master’s in Pharmaceutical Sciences from University of Montreal, both in Quebec, Canada.
Positions
- Company NameSpruce Biosciences, Inc.Stock CodeSPRBPositionSenior Vice President of Clinical Development Operations
